Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Apr;14(2):271-279.
doi: 10.1007/s13730-024-00933-8. Epub 2024 Nov 7.

Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction

Affiliations
Case Reports

Managing malignant hypertension with renal TMA: a case for caution in blood-pressure reduction

Narumichi Iwamura et al. CEN Case Rep. 2025 Apr.

Abstract

Malignant hypertension with renal thrombotic microangiopathy is a rare yet serious cause of acute kidney injury (AKI). Patients are often treated with antihypertensive therapy; however, managing their blood pressure is complex, with targets for initial treatment unclear. We report on a 55-year-old male with severe hypertension (blood pressure 210/140 mmHg), AKI (serum creatinine 9.27 mg/dL), anemia (hemoglobin 7.6 g/dL), thrombocytopenia (platelets 113 k/μL), and renal biopsy confirming malignant arteriolar nephrosclerosis and thrombotic microangiopathy. Previously prescribed 20-mg azilsartan daily, he lost consciousness the next day and was urgently admitted with a blood pressure of 118 mmHg and increased serum creatinine from 1.28 to 9.27 mg/dL over 6 months. Azilsartan was stopped; blood pressure managed with 12.5 mg of losartan daily, targeting systolic pressure between 150 and 160 mmHg. His creatinine peaked on day 14; however, treatment with 12.5 - 50 mg/day of losartan and 5 - 10 mg/day of amlodipine gradually improved renal function to 4.48 mg/dL by month ten without hemodialysis or further syncope. Our case suggests a gradual approach to blood-pressure management to avoid ischemic risks.

Keywords: Acute kidney injury (AKI); Antihypertensive therapy; Blood-pressure management; Malignant hypertension; Renal thrombotic microangiopathy (TMA).

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors have declared that no conflict of interest exists. The authors declare that they have no known competing financial interests or personal relationships that could have influenced the work reported in this paper. Informed consent: Informed consent was obtained from all participants.

Figures

Fig. 1
Fig. 1
Time course. UPCR, urinary protein/urinary creatinine; SBP, systemic blood pressure; Hb, hemoglobin; PLT, platelet; sCre, serum creatinine
Fig. 2
Fig. 2
Fundoscopy findings on Day 2. a. Right fundus image. b. Left fundus image. Fundus examination on Day 2 revealed retinal edema, cottony leukoplakia, hemorrhages, and moderately narrowing of arteries, indicating Keith–Wagener group 3 hypertensive retinopathy findings
Fig. 3
Fig. 3
Renal histology. a. An interlobular arteriole shows an “onion skin” lesion (allow), indicative of concentric proliferation of smooth muscle cells and fibrous components within the intima. Stained with Azan, 400 × magnification. b. Mucoid-like intimal edema causing luminal narrowing is observed in the afferent arterioles (allow). Stained with Periodic acid-Schiff, 400 × magnification. c. Swelling of endothelial cells is noted (allow). Stained with Periodic acid-Schiff, 400 × magnification. d. Intimal edema with karyorrhexis and entrapment of red-blood cells is present (allow). Stained with Periodic acid-Schiff, 400 × magnification. e. Intimal edema with fibrin deposition is evident (allow). Stained with Periodic acid-Schiff, 400 × magnification. f. Mucoid intimal edema with entrapment of red-blood cells (yellow allow) and associated collapse of the glomerulus (blue allow) is seen. Stained with Periodic acid-methenamine-silver, 400 × magnification. g. Double contours of the glomerular basement membrane and endocapillary hypercellularity are observed (allow). Stained with Periodic acid-methenamine-silver, 400 × magnification. h. Partial deposition of C3 is seen in some glomeruli without specific deposition of other immune complexes. The immunofluorescence antibody assay revealed no specific immune complex deposition. Immunofluorescent staining, 400 × magnification. i. Wrinkled glomerular basement membranes and semidiffuse effacement of podocyte foot processes are observed. Viewed with electron microscopy, 1500 × magnification

References

    1. Shantsila A, Lip GYH. Malignant hypertension revisited—does this still exist? Am J Hypertens. 2017;30:543–9. 10.1093/ajh/hpx008. - DOI - PubMed
    1. Amraoui F, Van Der Hoeven NV, Van Valkengoed IGM, et al. Mortality and cardiovascular risk in patients with a history of malignant hypertension: a case-control study. J Clin Hypertens. 2014;16:122–6. 10.1111/jch.12243. - DOI - PMC - PubMed
    1. Nzerue C, Oluwole K, Adejorin D, et al. Malignant hypertension with thrombotic microangiopathy and persistent acute kidney injury (AKI). Clin Kidney J. 2014;7:586–9. 10.1093/ckj/sfu116. - DOI - PMC - PubMed
    1. Genest DS, Patriquin CJ, Licht C, et al. Renal thrombotic microangiopathy: a review. Am J Kidney Dis. 2023;81:591–605. 10.1053/j.ajkd.2022.10.014. - DOI - PubMed
    1. Unger T, Borghi C, Charchar F, et al. 2020 International Society of Hypertension Global Hypertension practice guidelines. Hypertens. 2020;75:1334–57. 10.1161/HYPERTENSIONAHA.120.15026. - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources